Development of Novel Micro-dystrophins with Enhanced Functionality

Gene therapies using adeno-associated viral (AAV) vectors have advanced into clinical trials for several diseases, including Duchenne muscular dystrophy (DMD). A limitation of AAV is the carrying capacity (∼5 kb) available for genes and regulatory cassettes (RCs). These size constraints are problema...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Julian N., Hollinger, Katrin, Bengtsson, Niclas E., Allen, James M., Hauschka, Stephen D., Chamberlain, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403485/
https://www.ncbi.nlm.nih.gov/pubmed/30718090
http://dx.doi.org/10.1016/j.ymthe.2019.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403485/
https://www.ncbi.nlm.nih.gov/pubmed/30718090
http://dx.doi.org/10.1016/j.ymthe.2019.01.002

Ejemplares similares